Related Experiment Video
Updated: Nov 12, 2025

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
YAP-dependent proliferation by a small molecule targeting annexin A2
Sophia Z Shalhout1,2,3, Peng-Yu Yang4,5, Edyta M Grzelak4
1Stem Cell Program, Boston Children's Hospital, Boston, MA, USA.
Researchers discovered PY-60, a small molecule that activates Yes-associated protein (YAP) transcriptional activity. This molecule promotes skin cell regeneration and reveals annexin A2 as a potential therapeutic target for regenerative medicine.
Area of Science:
- Molecular Biology
- Cell Biology
- Regenerative Medicine
Background:
- The transcriptional coactivator Yes-associated protein (YAP) regulates cell proliferation and tissue regeneration.
- Activating YAP holds therapeutic potential for diseases with impaired regenerative repair.
Purpose of the Study:
- To identify small molecules that activate YAP transcriptional activity.
- To elucidate the mechanism of YAP activation and its therapeutic implications.
Main Methods:
- In vitro assays to measure YAP transcriptional activity.
- Topical drug administration in mice to assess epidermal keratinocyte expansion.
- Chemical proteomics to identify the molecular target of the small molecule.
Main Results:
- Discovery of PY-60, a small molecule that robustly activates YAP.
- PY-60 promotes YAP-dependent epidermal keratinocyte expansion in mice.
- Annexin A2 (ANXA2) identified as the direct target of PY-60.
- PY-60 treatment causes ANXA2 release from the cell membrane, activating YAP.
Conclusions:
- Annexin A2 is a novel, druggable component of the Hippo pathway.
- PY-60 activates YAP by modulating ANXA2.
- This study provides a mechanistic basis for promoting regenerative repair through YAP activation.
More Related Videos
Related Concept Videos
The Intrinsic Apoptotic Pathway
Anaphase Promoting Complex
Intracellular Signaling Affects Focal Adhesions
Some...
The Extrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
cAMP-dependent Protein Kinase Pathways

